Post Hoc Analyses of Anxiety Measures in Adult Patients With Generalized Anxiety Disorder Treated With Vilazodone

OBJECTIVE: To investigate vilazodone, currently approved for major depressive disorder in adults, for generalized anxiety disorder (GAD). METHOD: Three randomized, double-blind, placebo-controlled studies showing positive results for vilazodone (2,040 mg/d) in adult patients with GAD (DSM-IV-TR) wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Arif, Durgam, Suresh, Tang, Xiongwen, Ruth, Adam, Mathews, Maju, Gommoll, Carl P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Physicians Postgraduate Press, Inc. 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956429/
https://www.ncbi.nlm.nih.gov/pubmed/27486544
http://dx.doi.org/10.4088/PCC.15m01904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956429/
https://www.ncbi.nlm.nih.gov/pubmed/27486544
http://dx.doi.org/10.4088/PCC.15m01904

Ejemplares similares